← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2013Last known activity
Oct 31, 2024
Timeline
1000s
- Jan 1, 1000
Centre Hospitalier Régional d'Orléans— Founded
Drugs by trial phase (10 distinct, 9 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT06589258Lead sponsorN/AOct 31, 2024
- NCT05306249Lead sponsorPhase 2May 16, 2022
- NCT05306249Overall official - principal investigatorPhase 2May 16, 2022
- NCT04148443Lead sponsorN/ANov 30, 2019
- NCT04137302Study directorPhase 4Nov 1, 2019
- NCT04137302Lead sponsorPhase 4Nov 1, 2019
- NCT03849508Overall official - principal investigatorPhase 4Feb 27, 2019
- NCT03849508Lead sponsorPhase 4Feb 27, 2019
- NCT03488628Overall official - principal investigatorN/ASep 30, 2018
- NCT03488628Lead sponsorN/ASep 30, 2018
- NCT02765074Lead sponsorPhase 4Jun 1, 2016
- NCT02596334Lead sponsorPhase 3Dec 23, 2015
- NCT01817153Reponsible party - principal investigatorPhase 2/Phase 3Nov 1, 2013
- NCT01817153Lead sponsorPhase 2/Phase 3Nov 1, 2013
Details
- Founded
- Orléans, FR Jan 1, 1000
- Last known activity
- Oct 31, 2024